← Back to headlines
Mega Lifesciences Posts Strong Half-Year Results Despite Share Price Decline
The biotech company reported a 12.5% revenue increase and a 33% jump in profit for the first half of 2026, even as its stock price experienced downward pressure.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
US Investigates Strike That Killed Guests at Iranian Wedding
32m ago
Volkswagen Board Approves 100,000 Job Cuts in Major Global Restructuring
53m ago
Japan Household Spending Drops 3.6% in July for Eighth Consecutive Month
1h ago
Trump Administration Asks Supreme Court to Reinstate Mail Voting Rules
1h ago